87 results were found based on your search term
The test was developed in the University’s bio-incubator, the BioHub Birmingham, and the trials are the culmination of eight years of collaborative research
Cellular work has found mutation in gene that leads to disease progression in myelodysplastic syndromes (MDS)
Discovery of DIAL syndrome could enable patients to have more personalised cancer care to reduce risk of chemotherapy toxicity
The University Â鶹¾«Ñ¡ has been a driving force in understanding Epstein-Barr Virus and its connection with cancer for many years.
Health care providers and academics across the West Midlands have been recognised for their outstanding treatment, care and research for brain tumours.
The MRC has announced that Birmingham’s Professor Jo Morris will become the new Chair of the MRC Molecular and Cellular Medicine Board (MCMB).
Researchers have received a significant funding boost to understand how genetic processes impact development and cancer growth.
Advances in understanding how cells repair DNA damage could improve future cancer treatments
